Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2025-02-24 to 2025-02-25
Current total value of award: $18.5
Description: 4567372602!APAP/COD CIII 300/30MG TAB MAL